Insider Trading28 Sept 2026, 03:53 pm
Kilitch Drugs India Ltd Closes Trading Window for Q3 FY27 Results
AI Summary
Kilitch Drugs India Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code. The window will be shut from October 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ending September 30, 2026. The exact date for the Board of Directors' meeting to approve these results will be communicated later.
Key Highlights
- Trading window closed for designated persons and relatives.
- Closure effective from October 1, 2026.
- Window reopens 48 hours post Q3 FY27 financial results declaration.
- Compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
- Board meeting date for results approval to be announced.
Price Impact
More from KILITCH